The latest biotech news

world health organization genomics pathogen pandemic

News and Trends 5 Apr 2022

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

The World Health Organization has released a 10-year plan to monitor the genetic make-up of pathogens across the globe. The strategy highlights how far genomics has come during the Covid-19 pandemic and how far there is to go. The past two years have seen unprecedented global collaboration as researchers raced to better understand the epidemiology, […]

April 5, 2022 - 4 minutesmins - By Anita Chakraverty

News and Trends 1 Apr 2022

Europe Shuns Russian Covid-19 Vaccines as Ukraine War Continues

In the last two years, Russian Covid-19 vaccine makers had a tough time penetrating the European market with their flagship vaccine, Sputnik V. This year, Russia’s invasion of Ukraine has likely dashed Sputnik V’s chances of reaching Europe anytime soon. Just months after the Covid-19 pandemic began, Russia was the first country to approve a […]

April 1, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 31 Mar 2022

Precision Medicine Startups Increase Focus on Data Access and Privacy

Low-cost genetic sequencing is becoming increasingly accessible and profitable for companies, but data protection and ownership remains a key issue for many individuals. Sano Genetics is one of many firms driving precision medicine by creating a more mutually beneficial relationship between patients and pharma companies. The falling costs of DNA sequencing are leading to serious […]

March 31, 2022 - 4 minutesmins - By Anita Chakraverty

News and Trends 30 Mar 2022

BIO-Europe Spring 2022: The Highlights

BIO-Europe Spring is one of Europe’s biggest biotech partnering events with discussion topics ranging from platform technologies and manufacturing to biotech investments. Here are some of the key take-home reports from the proceedings, published as they happen. BIO-Europe Spring 2022 is in full swing this week with a long lineup of online topic discussions. Labiotech.eu […]

March 30, 2022 - 13 minutesmins - By Editorial Team

gene therapy bacteria ilya pharma lactic acid

News and Trends 23 Mar 2022

Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding

Cell and gene therapies are taking off in a big way in Europe. As the buzz grows, the Swedish firm Ilya Pharma has raised €8.5M to lay down the foundations of bacterial gene therapies for enterocolitis and diabetic ulcers. Investor interest in cell and gene therapy is ramping up fast around the world, with a […]

March 23, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 22 Mar 2022

Biotechs Carve out Niches in Cystic Fibrosis Treatment Space

Cystic fibrosis has proved resistant to treatments that provide long-lasting respite from the sticky mucus that affects the lungs and other organs. Emerging biotechs such as Kither Biotech as well as the old guard including Vertex are finding new ways to tackle the inherited disease. Cystic fibrosis is best known for causing thick mucus in […]

March 22, 2022 - 5 minutesmins - By Anita Chakraverty

radiopharmaceutical treatments precirix jeito

News and Trends 17 Mar 2022

€80M Series B Establishes European Champion in Radiopharmaceuticals

Big European venture capital firms Jeito, Forbion, and Inkef Capital have teamed up to propel the local radiopharmaceutical scene by investing €80M in the Belgian firm Precirix. Europe has a long history of expertise in the development of radiopharmaceutical drugs. One of the pioneers in the field was Advanced Accelerator Applications (AAA) in France. AAA […]

March 17, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 15 Mar 2022

Biotech Stocks in “Total Eclipse” as Financial Pressures Mount

More than a year after biotech stock indices peaked, the markets are worse than ever. Meanwhile, rumors of an impending wave of opportunistic biotech acquisitions are yet to materialize. In February of last year, biotech stocks across Europe and the US saw the end of a pandemic-fuelled growth spurt. Since then, the stock growth of […]

March 15, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 11 Mar 2022

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis. Microbiotica’s financing sets a record in Europe for microbiome specialist biotechs. The round was co-led by Sweden’s Flerie Invest and China-based Tencent, and was supported […]

March 11, 2022 - 3 minutesmins - By Victor Kotsev

Scenic biotech lysosomal storage disorders

News and Trends 10 Mar 2022

Emerging Startups Take Aim at Lysosomal Storage Disorders

Lysosomal storage disorders such as Niemann-Pick type C have proved difficult to tackle in the biotech industry. With recent funding rounds in the bag, Scenic Biotech and Maze Therapeutics strive to treat these conditions by activating protective genes. Lysosomal storage disorders are inherited conditions caused by mutations in metabolic enzymes found inside our cells, leading […]

March 10, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 8 Mar 2022

The Top European Biotech Investments in February 2022

Companies developing lab automation, ophthalmological treatments, and novel foods received Europe’s top biotech investments in February 2022. European and Israeli biotech investments in February 2022 narrowly beat January’s performance. Life sciences companies in these regions bagged 52 private investments and initial public offerings (IPOs), worth €664M in total. Meanwhile, January’s tally was 41 deals totaling […]

March 8, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 3 Mar 2022

Europe’s Ophthalmology Scene Stays Hot for Biotech Funding

Ophthalmology-focused startups had a record year for venture capital funding in 2021. Impressive Series A rounds and collaborations hint at a continuing upward trend for the field in 2022. Biotech companies researching treatments for ophthalmological conditions experienced a splurge of venture capital (VC) funding in 2021, with the total more than trebling the haul from […]

March 3, 2022 - 5 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

Europe Shuns Russian Covid-19 Vaccines as Ukraine War Continues

Precision Medicine Startups Increase Focus on Data Access and Privacy

BIO-Europe Spring 2022: The Highlights

Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding

Biotechs Carve out Niches in Cystic Fibrosis Treatment Space

€80M Series B Establishes European Champion in Radiopharmaceuticals

Biotech Stocks in “Total Eclipse” as Financial Pressures Mount

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Emerging Startups Take Aim at Lysosomal Storage Disorders

The Top European Biotech Investments in February 2022

Europe’s Ophthalmology Scene Stays Hot for Biotech Funding

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!